1997
DOI: 10.1007/pl00005597
|View full text |Cite
|
Sign up to set email alerts
|

Recovery of locomotor activity in the adult chronic spinal rat after sublesional transplantation of embryonic nervous cells: specific role of serotonergic neurons

Abstract: Locomotor movements are programmed in a specialised neuronal network that is localised in the central nervous system and referred to as the central pattern generator (CPG) for locomotion. This CPG can be activated by pharmacological agents such as monoamines. The aim of the present study was to try to activate the CPGs by using cells that are supposed to release serotonin locally. Adult chronic spinal rats were injected with embryonic brainstem neurons within the spinal cord under a thoracic transection. This … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
63
0

Year Published

1999
1999
2012
2012

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 107 publications
(66 citation statements)
references
References 47 publications
3
63
0
Order By: Relevance
“…We observed that quipazine enabled hindlimb bipedal stepping in complete spinal mice, an observation consistent with findings reported by Guertin (2004). Quipazine and another serotonin agonist, m-chloropiperazine, have been shown to facilitate locomotion in cats (Barbeau and Rossignol, 1990) and rats (Kim et al, 2001), respectively, and similar improvement was reported when serotonergic embryonic raphe cells were implanted in spinal rats (Feraboli-Lohnherr et al, 1997;Kim et al, 1999;Dumoulin et al, 2000;Ribotta et al, 2000). The mechanism by which serotonin mediates locomotor improvement after SCI is not well understood.…”
Section: Discussionsupporting
confidence: 89%
“…We observed that quipazine enabled hindlimb bipedal stepping in complete spinal mice, an observation consistent with findings reported by Guertin (2004). Quipazine and another serotonin agonist, m-chloropiperazine, have been shown to facilitate locomotion in cats (Barbeau and Rossignol, 1990) and rats (Kim et al, 2001), respectively, and similar improvement was reported when serotonergic embryonic raphe cells were implanted in spinal rats (Feraboli-Lohnherr et al, 1997;Kim et al, 1999;Dumoulin et al, 2000;Ribotta et al, 2000). The mechanism by which serotonin mediates locomotor improvement after SCI is not well understood.…”
Section: Discussionsupporting
confidence: 89%
“…Interestingly, overdose of SSRI in non-SCI patients has been linked to the development of serotonin syndrome, in which hypertonus of lower limbs is often a symptom (Whipp and Waterfield, 2004). In contrast to these negative effects, administration of SSRI in transected animals transplanted with embryonic serotonergic cells improved locomotor recovery (Feraboli-Lohnherr, et al, 1997). Similar studies in contusive SCI models have not yet been reported, but both beneficial as well as detrimental effects of SSRI may be expected depending on the SCI severity and the time of SSRI administration.…”
Section: Discussionmentioning
confidence: 99%
“…These results demonstrate that the improved stepping was a function of the repetitive activation of the sensorimotor pathways that was enabled by quipazine treatment. Further evidence that the serotonergic system can be used to facilitate the recovery of locomotion in complete spinal rats has been demonstrated by Orsal and colleagues (Feraboli-Lohnherr et al, 1997;Ribotta et al, 2000). They transplanted embryonic raphe cells secreting 5-HT in the spinal cord distal (T11) to a complete lesion at T8.…”
Section: Use-dependent Plasticitymentioning
confidence: 97%